ID17875A - Komposisi farmasi yang mengandung asam 4-oksobutanoat - Google Patents

Komposisi farmasi yang mengandung asam 4-oksobutanoat

Info

Publication number
ID17875A
ID17875A IDP972848A ID972848A ID17875A ID 17875 A ID17875 A ID 17875A ID P972848 A IDP972848 A ID P972848A ID 972848 A ID972848 A ID 972848A ID 17875 A ID17875 A ID 17875A
Authority
ID
Indonesia
Prior art keywords
oxsobutanoic
acid
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
IDP972848A
Other languages
English (en)
Inventor
Gerard Moinet
Philippe Mayzeray
Liliane Doare
Micheline Kergoat
Didier Mesangeau
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of ID17875A publication Critical patent/ID17875A/id

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/60Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/76Unsaturated compounds containing keto groups
    • C07C59/84Unsaturated compounds containing keto groups containing six membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/738Esters of keto-carboxylic acids or aldehydo-carboxylic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/10Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/16Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Furan Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
IDP972848A 1996-08-16 1997-08-14 Komposisi farmasi yang mengandung asam 4-oksobutanoat ID17875A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9610254A FR2752422B1 (fr) 1996-08-16 1996-08-16 Composition pharmaceutique contenant des acides 4-oxo-butanoiques

Publications (1)

Publication Number Publication Date
ID17875A true ID17875A (id) 1998-02-05

Family

ID=9495089

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP972848A ID17875A (id) 1996-08-16 1997-08-14 Komposisi farmasi yang mengandung asam 4-oksobutanoat

Country Status (30)

Country Link
US (1) US6143787A (id)
EP (1) EP0925273B1 (id)
JP (1) JP3105545B2 (id)
KR (1) KR100488430B1 (id)
CN (1) CN1082370C (id)
AR (1) AR009251A1 (id)
AT (1) ATE208364T1 (id)
AU (1) AU725440B2 (id)
BR (1) BR9711315A (id)
CA (1) CA2263348C (id)
CY (1) CY2298B1 (id)
CZ (1) CZ294165B6 (id)
DE (1) DE69708130T2 (id)
DK (1) DK0925273T3 (id)
ES (1) ES2166098T3 (id)
FR (1) FR2752422B1 (id)
HK (1) HK1021728A1 (id)
HU (1) HUP0004223A3 (id)
ID (1) ID17875A (id)
NO (1) NO312290B1 (id)
PL (1) PL187371B1 (id)
PT (1) PT925273E (id)
RU (1) RU2175966C2 (id)
SI (1) SI0925273T1 (id)
SK (1) SK283055B6 (id)
TR (1) TR199900329T2 (id)
TW (1) TW438764B (id)
UA (1) UA57031C2 (id)
WO (1) WO1998007681A1 (id)
ZA (1) ZA977327B (id)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04318852A (ja) * 1991-04-18 1992-11-10 Fujitsu Ltd レジスト・パターン形成方法
HU230352B1 (hu) 2001-06-12 2016-02-29 Wellstat Therapeutics Corporation Metabolikus rendellenességek kezelésére adható vegyületek és ezeket tartalmazó gyógyászati készítmények
FR2832633B1 (fr) * 2001-11-28 2004-09-24 Lipha Composition pharmaceutique comprenant une association metformine et un acide 4-oxo-butanoique et son utilisation pour traiter le diabete
FR2832925B1 (fr) * 2001-12-03 2006-07-14 Lipha Utilisation de derives de l'acide 4-oxobutanoique dans le traitement de l'inflammation
FR2834214B1 (fr) * 2001-12-28 2004-09-24 Lipha Composition pharmaceutique comprenant un inhibiteur d'alpha-glucosidase et un acide 4-oxo-butanoique et son utilisation pour traiter le diabete
FR2834640B1 (fr) * 2002-01-11 2004-09-24 Lipha Composition pharmaceutique comprenant une glitazone et un acide 4-oxobutanoique et son utilisation pour traiter le diabete
EP1556085A4 (en) * 2002-11-01 2012-08-22 Wellstat Therapeutics Corp COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS
ATE468114T1 (de) * 2002-11-08 2010-06-15 High Point Pharmaceuticals Llc Sichere chemische entkuppler zur behandlung von fettsucht
FR2849599B1 (fr) * 2003-01-07 2006-12-29 Merck Sante Sas Utilisation d'inhibiteurs de la kynurenine-3-hydroxylase pour le traitement du diabete
FR2849598B1 (fr) * 2003-01-07 2006-09-22 Merck Sante Sas Utilisation d'inhibiteurs de la kynurenine-3-hydroxylase pour le traitement du diabete, par augmentation du nombre de cellules des ilots de langerhans
CN101912380A (zh) * 2003-04-15 2010-12-15 维尔斯达医疗公司 用于治疗代谢紊乱的化合物
WO2009071161A1 (en) 2007-12-03 2009-06-11 Merck Patent Gmbh Use of 4-oxobutanoic acid derivatives in the treatment of pathologies associated with immunological disorders

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5250517A (en) * 1987-10-06 1993-10-05 Hoffmann-La Roche Inc. Renin inhibiting compounds
DK523288A (da) * 1987-10-06 1989-04-07 Hoffmann La Roche Aminosyrederivater
US5055466A (en) * 1987-11-23 1991-10-08 E. R. Squibb & Sons, Inc. N-morpholino derivatives and their use as anti-hypertensive agents
CA1329680C (en) * 1987-11-23 1994-05-17 Harold Norris Weller, Iii N-heterocyclic alcohol derivatives

Also Published As

Publication number Publication date
TR199900329T2 (xx) 1999-04-21
SK283055B6 (sk) 2003-02-04
HK1021728A1 (en) 2000-06-30
CY2298B1 (en) 2003-07-04
DE69708130T2 (de) 2002-06-20
FR2752422B1 (fr) 1998-11-06
US6143787A (en) 2000-11-07
UA57031C2 (uk) 2003-06-16
PT925273E (pt) 2002-04-29
CZ49899A3 (cs) 1999-05-12
EP0925273B1 (fr) 2001-11-07
PL187371B1 (pl) 2004-06-30
CZ294165B6 (cs) 2004-10-13
NO990707D0 (no) 1999-02-15
CA2263348C (en) 2008-05-13
JP2000506543A (ja) 2000-05-30
FR2752422A1 (fr) 1998-02-20
JP3105545B2 (ja) 2000-11-06
SK18099A3 (en) 2000-03-13
RU2175966C2 (ru) 2001-11-20
CN1227538A (zh) 1999-09-01
KR20000068106A (ko) 2000-11-25
WO1998007681A1 (fr) 1998-02-26
ZA977327B (en) 1998-03-30
AU725440B2 (en) 2000-10-12
ATE208364T1 (de) 2001-11-15
TW438764B (en) 2001-06-07
NO990707L (no) 1999-02-15
NO312290B1 (no) 2002-04-22
ES2166098T3 (es) 2002-04-01
HUP0004223A2 (hu) 2001-04-28
SI0925273T1 (en) 2002-04-30
KR100488430B1 (ko) 2005-05-10
EP0925273A1 (fr) 1999-06-30
DK0925273T3 (da) 2002-02-18
AU3942297A (en) 1998-03-06
DE69708130D1 (de) 2001-12-13
HUP0004223A3 (en) 2001-12-28
CA2263348A1 (fr) 1998-02-26
BR9711315A (pt) 1999-08-17
AR009251A1 (es) 2000-04-12
CN1082370C (zh) 2002-04-10
PL331645A1 (en) 1999-08-02

Similar Documents

Publication Publication Date Title
ID20807A (id) Asam sulfonilaminokarboksilat
ID20809A (id) Asam diaminokarboksilat tersubstitusi
ID24686A (id) Enzim-enzim biosintetik asam amino tanaman
NO20004345L (no) Farmasøytisk sammensetning
ID18352A (id) Komposisi-komposisi farmasi
ID22053A (id) Turunan asam aminofosfonat dalam sediaan farmasi
ID24596A (id) Mikrosfer-mikrosfer farmasi yang mengandung asam valproat untuk pemakaian oral
ID17875A (id) Komposisi farmasi yang mengandung asam 4-oksobutanoat
ID18712A (id) Turunan-turunan asam 4-bifenil-4-hidroksibutirat tersubtitusi sebagai penghambat matriks metaloprotease
EE9800400A (et) Diklofenaaki sisaldavad farmatseutilised kompositsioonid
ID29294A (id) Komposisi farmasi
BR9507768A (pt) Composição farmacêutica
LV11727A (lv) Farmaceitiska kompozicija
ID18698A (id) Komposisi farmasi
ID25857A (id) Komposisi farmasi
ITMI942166A0 (it) Composizioni farmaceutiche miorilassanti
FI973280A0 (fi) Farmaseuttinen koostumus
ID27729A (id) Komposisi-komposisi anti-enzim yang mengandung asam etilendiamin disuksinat
DE69736678D1 (de) Dermatologische zusammensetzungen
ID17052A (id) Turunan-turunan asam asetat terapeutik
ID21355A (id) Pembuatan asam adipat
ID22212A (id) Turunan-turunan asam hidroksamat
ITMI962628A0 (it) Composizione farmaceutica
FI962738A (fi) Farmaseuttiset koostumukset
BR9605777A (pt) Composição farmacêutica